发明名称 LOX-1 GENE DEFECTIVE ANIMAL
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a gene-modified animal in which the expression of a LOX-1 gene pair is inactivated, capable of being used for elucidating physiological activities of the LOX-1 in an individual body level and enabling the utilization of the same for a research on a therapeutic agent, etc., of diseases including arteriosclelosis, etc., associated with the gene. <P>SOLUTION: This LOX-1 defective mouse is produced by a gene-targeting method. By an analysis using the produced LOX-1 gene defective mouse, it becomes clear that a LOX-1 antagonist is useful for improving a morbid state caused by the lowering of endothelial function. Also, it becomes clear that the LOX-1 is associated with an infection with a protozoan. Thus, the LOX-1 gene defective animal is a useful model for elucidating a new function of the LOX-1. The knock out mouse of the function of the LOX-1 gene becomes a useful model mouse for exploring the unknown role of the LOX-1 gene in the onset and development of the arteriosclerosis, etc. <P>COPYRIGHT: (C)2004,JPO&NCIPI</p>
申请公布号 JP2004208662(A) 申请公布日期 2004.07.29
申请号 JP20030002668 申请日期 2003.01.08
申请人 NATIONAL CARDIOVASCULAR CENTER;CHUGAI PHARMACEUT CO LTD 发明人 SAWAMURA TATSUYA;SUZUKI HIROSHI;KAWASE YOSUKE
分类号 A01K67/027;A61K39/395;A61K45/00;A61P3/06;A61P3/10;A61P7/02;A61P9/10;A61P9/12;A61P29/00;A61P33/00;A61P43/00;C12N5/10;C12N15/09;C12Q1/02;G01N33/15;G01N33/48;G01N33/50;(IPC1-7):C12N15/09 主分类号 A01K67/027
代理机构 代理人
主权项
地址